本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

23.89
+0.50502.16%
成交量:204.47萬
成交額:4,889.38萬
市值:29.87億
市盈率:110.88
高:24.18
開:23.63
低:23.55
收:23.38
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:0.90
換手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:13.54
市盈率(LYR):-188.28

資料載入中...

2021/11/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股變動聲明

3/A [Amend] - Initial statement of beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

重要事件披露

8-K - Current report
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/26

重要事件披露

8-K - Current report
2021/02/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership